Spautin-1, a novel autophagy inhibitor, enhances imatinib-induced apoptosis in chronic myeloid leukemia

By                  

International Journal of Oncology, Vol. 44, Iss. 5, 2014-01 ,pp. : 1661-1668

Spandidos Publications

Access to resources Recommend Favorite

Resistance to Rapamycin: A Novel Anticancer Drug

By Huang S.   Houghton P.J.  

Cancer and Metastasis Reviews, Vol. 20, Iss. 1-2, 2001-03 ,pp. : 71-80

Springer Publishing Company

Access to resources Recommend Favorite

A phase I clinical and pharmacokinetic study of the multi-drug resistance protein-1 (MRP-1) inhibitor sulindac, in combination with epirubicin in patients with advanced cancer

By O’Connor R.   O’Leary M.   Ballot J.   Collins C.   Kinsella P.   Mager D.   Arnold R.   O’Driscoll L.   Larkin A.   Kennedy S.   Fennelly D.   Clynes M.   Crown J.  

Cancer Chemotherapy and Pharmacology, Vol. 59, Iss. 1, 2007-01 ,pp. : 79-87

Springer Publishing Company

Access to resources Recommend Favorite

A248, a novel synthetic HDAC inhibitor, induces apoptosis through the inhibition of specificity protein 1 and its downstream proteins in human prostate cancer cells

By              

Molecular Medicine Reports, Vol. 8, Iss. 1, 2013-01 ,pp. : 195-200

Spandidos Publications

Access to resources Recommend Favorite

Structure-activity relationship of indomethacin analogues for MRP-1, COX-1 and COX-2 inhibition - identification of novel chemotherapeutic drug resistance modulators

By Touhey S.   O'Connor R.   Plunkett S.   Maguire A.   Clynes M.  

European Journal of Cancer, Vol. 38, Iss. 12, 2002-08 ,pp. : 1661-1670

Elsevier

Access to resources Recommend Favorite